# GATE 5 RISK-TIER IMPACT ANALYSIS

**Date:** 2026-10-03  

## 1. Theoretical Impact
As proven mathematically, the R3 risk tier (threshold 0.75) is blocked by a 0.65 trust ceiling. If any candidate was evaluated under R3 weights, it was unconditionally rejected by the `EvidenceEligibilityGate`.

## 2. Observed Historical Impact (Gate 5)
**Status:** `REQUIRES HUMAN RESEARCH DECISION / QUERY LOG AUDIT`

While R3 is theoretically impassable, it is highly probable that the historical Gate 5 experiments primarily utilized R1 and R2 standard pharmacological queries (e.g., standard DDI or ADE lookups without immediate lethal risk triggers). 

- **If no R3 queries were present in Gate 5:** The 0.65 trust ceiling *never actually caused a false rejection* in the historical baseline. The pipeline functioned successfully for all presented test cases.
- **If R3 queries were present in Gate 5:** The pipeline rejected them (controlled abstention). Altering the Trust Policy now would reverse those abstentions, fundamentally altering the historical outcomes.

## 3. Conclusion
"R3 is mathematically impossible" is true, but "R3 affected Gate 5 outcomes" is **UNKNOWN** without querying the specific experiment logs. The research methodology must clarify whether R3 queries were explicitly scoped out of Gate 5, or if they were meant to be evaluated and subsequently failed.
